Stable nucleic acid lipid particle (SNALP)-enabled sirna-based therapy for hemorrhagic fever
Ended Cooperative Agreement Awarded Last action
- Award ID
- W81XWH0720016
- Recipient
-
Protiva Biotherapeutics Inc. UEI R9VYBEQJ57R8
- Awarding agency
-
Department of the Army
Department of Defense
- Obligated
- $1,611,758
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Not on record
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $790,177 | |
| Original award | $821,581 |
Quick answers
Who received award W81XWH0720016?
W81XWH0720016 was awarded to Protiva Biotherapeutics Inc. by Department of the Army (Department of Defense) on January 1, 2007.
How much is award W81XWH0720016 worth?
$1,611,758 has been obligated on W81XWH0720016.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award